MDD subtype 1 exhibited metal ion dysregulation and monoaminergic pathway disruption, with PLS1+ genes predominantly enriched in dopaminergic and GABAergic synaptic transmission pathways. The gene discussed is PLS1; the disease is major depressive disorder.